Division of Chemistry, Department of Science, Faculty of Science and Technology, Rajamangala University of Technology Krungthep, Bangkok, 10120, Thailand.
National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Khlong Luang, Pathum Thani, 12120, Thailand.
Mikrochim Acta. 2024 Oct 17;191(11):676. doi: 10.1007/s00604-024-06771-w.
A straightforward distance-based paper analytical device (dPAD) was developed for monitoring sarcosine levels in human samples for the rapid diagnosis and prognosis of prostate cancer and related symptoms. This assay eliminates the need for the expensive horseradish peroxidase (HRP) enzyme by utilizing carbon nanodots (CDs) as a peroxidase-like nanozyme. The proposed dPAD sensor consists of a sample zone pre-deposited with sarcosine oxidase (SOx) and CDs, and a detection zone containing 3,3',5,5'-tetramethylbenzidine (TMB). When a solution containing sarcosine is added to the sample zone, hydroxyl radicals (OH) are produced through SOx oxidation and subsequent peroxidase catalysis by the CDs. The formed OH radicals immediately flow to the detection zone via capillary force, where they oxidize TMB, resulting in a visible colour change from colourless to blue. Sarcosine quantification is effortlessly accomplished by measuring the distance of the blue colour in the detection zone. The developed dPAD offers a linear working range between 12.5 and 35.0 nmol L (R = 0.9959) and a detection limit (LOD) of 10.0 nmol L. This covers the clinical range for urinary sarcosine determination, thereby suggesting no additional sample preparation or dilution is needed. The sensor shows high precision with the highest relative standard deviation (RSD) of 4.58% and demonstrates excellent selectivity with no observed interferences. Furthermore, recovery studies in human control urine samples ranged from 98.67 to 101.50%, with the highest RSD of 2.03%. Correspondingly, our dPAD method showed a great match with the performance of a commercial ELISA method for detecting sarcosine in human control serum. The sensor is more cost-effective, user-friendly, and accessible than previous methods. Overall, the proposed method represents a promising analytical tool for sarcosine quantification. The concept is also applicable for broader analytical applications in detecting other biomolecules.
开发了一种简单的基于距离的纸分析装置(dPAD),用于监测人样中肌氨酸水平,以快速诊断和预测前列腺癌及相关症状。该测定法通过利用碳纳米点(CDs)作为过氧化物酶样纳米酶,消除了昂贵的辣根过氧化物酶(HRP)酶的需求。所提出的 dPAD 传感器由一个预先沉积有肌氨酸氧化酶(SOx)和 CDs 的样品区和一个含有 3,3',5,5'-四甲基联苯胺(TMB)的检测区组成。当含有肌氨酸的溶液添加到样品区时,通过 SOx 氧化和随后的 CDs 过氧化物酶催化产生羟基自由基(OH)。形成的 OH 自由基立即通过毛细作用力流向检测区,在那里它们氧化 TMB,导致颜色从无色变为蓝色。通过测量检测区中蓝色的距离,轻松实现肌氨酸的定量。开发的 dPAD 在 12.5 和 35.0 nmol L(R=0.9959)之间提供线性工作范围和检测限(LOD)为 10.0 nmol L。这涵盖了尿液肌氨酸测定的临床范围,因此不需要额外的样品制备或稀释。该传感器具有出色的精度,最高相对标准偏差(RSD)为 4.58%,并且具有出色的选择性,没有观察到干扰。此外,在人对照尿样中的回收率研究范围为 98.67%至 101.50%,最高 RSD 为 2.03%。相应地,我们的 dPAD 方法与用于检测人对照血清中肌氨酸的商业 ELISA 方法的性能非常匹配。该传感器比以前的方法更具成本效益、更用户友好且更易于获得。总体而言,该方法代表了一种用于肌氨酸定量的有前途的分析工具。该概念也适用于更广泛的分析应用,用于检测其他生物分子。